Cargando…

Use of Tofacitinib in the Management of COVID-19 Pneumonia

How to cite this article: Bande BD. Use of Tofacitinib in the Management of COVID-19 Pneumonia. Indian J Crit Care Med 2021; 25(10):1089–1090.

Detalles Bibliográficos
Autor principal:	Bande, Balasaheb D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645822/ https://www.ncbi.nlm.nih.gov/pubmed/34916738 http://dx.doi.org/10.5005/jp-journals-10071-24004

Ejemplares similares

Critically Ill Obstetric Patients and Fetomaternal Outcome
por: Bande, Balasaheb D
Publicado: (2020)

Goals of Care for Patients with Severe Comorbid Illnesses Hospitalized for an Acute Deterioration
por: Bande, Balasaheb
Publicado: (2022)

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
por: Guimarães, Patrícia O., et al.
Publicado: (2021)

Methotrexate/tofacitinib/tozinameran interaction: COVID-19 pneumonia: case report
Publicado: (2022)

Tofacitinib Associated with Reduced Intubation Rates in the Management of Severe COVID-19 Pneumonia: A Preliminary Experience
por: Singh, Pawan K, et al.
Publicado: (2021)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Tofacitinib, two-faced Janus in ulcerative colitis and Crohn’s disease?
por: Biemans, Vince BC, et al.
Publicado: (2020)

Tofacitinib
Publicado: (2012)

The Role of Tofacitinib in the Management of Alopecia Totalis
por: Hernandez-Montoya, Carlos, et al.
Publicado: (2019)

Deciphering Novel Mechanistic and Pharmacokinetic Effects of Tofacitinib in Intestinal Inflammation: Expect the Unexpected
por: Atreya, Raja, et al.
Publicado: (2021)

Case Report: Home-based Management of Severe COVID-19 with Low-dose Tofacitinib
por: Sharma, Ashish, et al.
Publicado: (2021)

Tofacitinib Treatment in Patients With Active COVID-19 Infection
por: Alajlan, Abdulmajeed M, et al.
Publicado: (2021)

Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
por: Dimitroulas, Theodoros
Publicado: (2023)

COVID-19 pneumonia: ARDS or not?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Erratum to Tofacitinib
Publicado: (2012)

Weniger Lungenschaden mit Tofacitinib bei COVID-19-Pneumonie
por: Dovjak, Peter
Publicado: (2021)

Can Tofacitinib Offer Protection against COVID-19 Infection?
por: Goldberger, Tal, et al.
Publicado: (2021)

Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
por: Shin, Wonsuk, et al.
Publicado: (2020)

Successful Use of Tofacitinib in Scleroderma Arthropathy
por: MV, Prakashini, et al.
Publicado: (2023)

Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib
por: Mendoza Alvarez, Lybil Briscia, et al.
Publicado: (2019)

Oral Tofacitinib Therapy for the Effective Management of Netherton Syndrome
por: Dodeja, Ajay, et al.
Publicado: (2023)

Mesalazine/tofacitinib/vedolizumab: COVID-19 infection: 3 case reports
Publicado: (2021)

Tofacitinib is not a biologic
por: Marren, Amy S.
Publicado: (2017)

COVID-19 pneumonia: The fight must go on
por: Revel, Marie-Pierre
Publicado: (2021)

Bacterial Coinfection in COVID-19 and Influenza Pneumonia
por: Musher, Daniel M.
Publicado: (2021)

Thrombosis and COVID-19 pneumonia: the clot thickens!
por: Price, Laura C., et al.
Publicado: (2020)

Dexamethasone/prednisone/tofacitinib: COVID-19, thromboembolic episodes and off-label use: case report
Publicado: (2021)

Treatment of Multiorgan Sarcoidosis With Tofacitinib
por: Damsky, William, et al.
Publicado: (2020)

European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib
por: Kawalec, Paweł, et al.
Publicado: (2017)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
por: Ly, Karen, et al.
Publicado: (2019)

Outcomes of Tofacitinib Use in an Irish Pediatric Cohort
por: Ryan, Niamh, et al.
Publicado: (2023)

Tofacitinib as a novel therapy in COVID-19 acute respiratory distress syndrome
por: Panda, Rajesh, et al.
Publicado: (2021)

Caracterización del uso de tofacitinib como tratamiento para COVID-19
por: Toribio Polanco, Fidel José, et al.
Publicado: (2022)

Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib
por: Inanc, Nevsun, et al.
Publicado: (2023)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
por: Kwok, Seung-Ki
Publicado: (2014)

Pneumocystis Jirovecii Pneumonia after Initiation of Tofacitinib Therapy in Rheumatoid Arthritis: Case-Based Review
por: Grigoropoulos, Ioannis, et al.
Publicado: (2019)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Tofacitinib in Hypertrophic Lichen Planus
por: SEIRINGER, Peter, et al.
Publicado: (2020)

Treatment of granuloma annulare with tofacitinib
por: Bosch‐Amate, Xavier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvtsmducd9lpuqeo3vl9dqm4t6